The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion
- PMID: 9278315
The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion
Abstract
To characterize the functional status of lpr T cells and determine whether activation is required for DN cell expansion, we performed in vivo labeling experiments in MRL-+/+, MRL-lpr, and p59fyn-/- MRL-lpr (Fyn-/-) mice. Multicolor FACS analysis of T cells from 8-wk-old mice receiving bromodeoxyuridine (BrdUrd) for 9 days showed that higher proportions of CD4+ and CD8+ lymph node cells were dividing (BrdUrd(high)) in lpr (15%) than in +/+ mice (3%), and the proportion of cycling cells was even higher in the DN (71%) and CD4+ B220+ (54%) lpr subsets. BrdUrd chase experiments documented that activation and division in most DN cells was initiated subsequent to their precursor CD8+ stage. Lymphadenopathy and other disease manifestations were greatly reduced in Fyn-/- lpr mice concomitant to decreased DN cells (from 77 to 20%). BrdUrd chase experiments showed that the division rate, signified by conversion of DN cells from BrdUrd(high) to BrdUrd(low), was severely reduced in Fyn-/- compared with conventional lpr mice, whereas division of all other T cell subsets (CD4+, CD8+, and CD4+ B220+) was equal in both types of mice. We conclude that 1) DN lpr T cells, rather than being end stage, retain the capacity to be activated and repeatedly divide before reaching an anergic or replicative senescence stage; 2) the CD3 zeta-chain-associated Fyn kinase is important to DN T cell signal transduction; 3) DN cells, as functional intermediates of the CD8+ subset, are highly dependent on Fas participation for apoptosis; and 4) DN cells contribute to the early development of the serologic and histologic features of the MRL-lpr lupus disease.
Similar articles
-
Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).J Immunol. 1997 Sep 1;159(5):2532-41. J Immunol. 1997. PMID: 9278347
-
Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.J Immunol. 1993 Apr 15;150(8 Pt 1):3651-67. J Immunol. 1993. PMID: 7682246
-
Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.J Immunol. 1998 Nov 15;161(10):5164-70. J Immunol. 1998. PMID: 9820486
-
MRL-lpr/lpr disease: theories meet Fas.Semin Immunol. 1994 Feb;6(1):55-69. doi: 10.1006/smim.1994.1009. Semin Immunol. 1994. PMID: 7513194 Review.
-
Autoimmunity in mice bearing lprcg: a novel mutant gene.Int Rev Immunol. 1994;11(3):193-210. doi: 10.3109/08830189409061727. Int Rev Immunol. 1994. PMID: 7930845 Review.
Cited by
-
Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice.J Clin Invest. 1998 Jan 15;101(2):364-71. doi: 10.1172/JCI750. J Clin Invest. 1998. PMID: 9435308 Free PMC article.
-
Double negative (DN) αβ T cells: misperception and overdue recognition.Immunol Cell Biol. 2015 Mar;93(3):305-10. doi: 10.1038/icb.2014.99. Epub 2014 Nov 25. Immunol Cell Biol. 2015. PMID: 25420721 Free PMC article. Review.
-
Tumour necrosis factor and other cytokines in murine lupus.Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I49-55. doi: 10.1136/ard.58.2008.i49. Ann Rheum Dis. 1999. PMID: 10577973 Free PMC article. Review. No abstract available.
-
Deficiency of the cyclin kinase inhibitor p21(WAF-1/CIP-1) promotes apoptosis of activated/memory T cells and inhibits spontaneous systemic autoimmunity.J Exp Med. 2004 Feb 16;199(4):547-57. doi: 10.1084/jem.20031685. J Exp Med. 2004. PMID: 14970181 Free PMC article.
-
A role for Fas in negative selection of thymocytes in vivo.J Exp Med. 1998 May 4;187(9):1427-38. doi: 10.1084/jem.187.9.1427. J Exp Med. 1998. PMID: 9565635 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Research Materials
Miscellaneous